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FOXP3promotes the development and function of regulatory
T cells mainly through regulating the transcription of target
genes. RNA alternative splicing has been implicated in a wide
range of physiological and pathophysiological processes. We
report here that FOXP3 associates with heterogeneous nuclear
ribonucleoprotein (hnRNP) F through the exon 2–encoded
region of FOXP3 and the second quasi-RNA recognition motif
(qRRM) of hnRNPF. FOXP3 represses the ability of hnRNPF to
bind to its target pre-mRNA and thus modulates RNA alterna-
tive splicing. Furthermore, overexpression ofmouse hnRNPF in
in vitro-differentiated regulatory T cells (Tregs) reduced their
suppressive function. Thus, our studies identify a novel mecha-
nism by which FOXP3 regulates mRNA alternative splicing to
modulate the function of regulatory T cells.
CD4CD25 regulatory T cells (Tregs)3 suppress immune
responses to self-antigen and commensal antigens although the
immune systemmounts defense against pathogens. FOXP3 is a
lineage-specific transcription factor for Tregs and its expres-
sion is required for the development and function of Tregs.
Ablation of the Foxp3 gene either duringTreg differentiation or
in mature Tregs abrogates their suppressive function (1). In
mice, a spontaneous mutation of Foxp3 results in scurfy pho-
notype, which is characterized by lack of Tregs and multiorgan
lethal autoimmunity (2). In humans the loss of FOXP3 function
caused by mutations attenuates the development and function
of Tregs and causes immunodysregulation polyendocrinopathy
enteropathy X-linked (IPEX) syndrome (3, 4).
FOXP3 is an X-linked forkhead/winged helix transcription
factor highly conserved between humans andmice. Upon bind-
ing to the promoters of target genes with its C-terminal fork-
head domain, FOXP3 either down- or up-regulates their
expression (5, 6). FOXP3 can also execute its activity in a fork-
head domain–independent manner. In recent years, multiple
nuclear proteins have been identified that associate with
FOXP3 (7–16). By forming a complex with other nuclear fac-
tors, FOXP3 regulates the expression of target genes that do not
contain binding sites for its forkhead domain (7).
A hallmark of higher eukaryotic gene expression is the
pre-mRNA splicing during transcription. Alternative splicing
of multi-exon genes not only regulates the stability, localiza-
tion, and translation of mature transcript by differential splic-
ing of the 5 or 3 UTRs, but also alters the protein structure,
even the ORF of genes, and thus provides an important
RNA-based layer of protein regulation and cellular function
(reviewed in Ref. 17). In humans, up to 95% ofmulti-exon genes
are estimated to undergo alternative splicing (18). It is pre-
dicted that alternative splicing events are overrepresented in
nervous and immune systems. For example, genes expressed in
immune systems undergo extensive alternative splicing with
60% of primary transcripts alternatively spliced in T or B lym-
phocytes (19). During T cell receptor (TCR) activation in pri-
mary and cultured T cells, over 50 genes with known functions
in immunobiology are validated to exhibit robust changes (20%
difference) in alternative splicing (17). Although these studies
have provided substantive evidence for the importance of alter-
native splicing in the adaptive immune response, whether alter-
native splicing is involved in the lineage differentiation and/or
function of helper T cells remains to be understood.
In current studies, we identified the association of FOXP3
and heterogeneous nuclear ribonucleoprotein F (hnRNPF).
hnRNPF belongs to the hnRNP family that consists of RNA-
binding nuclear proteins involved in multiple aspects of RNA
metabolism (20). hnRNPF is further grouped into a subfamily
with hnRNPH1, hnRNPH2, and hnRNPH3 because of their
conserved protein sequence and structure (21). We demon-
strate that FOXP3 represses the alternative splicing mediated
by hnRNPF whereas increased expression of hnRNPF over-
comes the repression of alternative splicing by FOXP3.We fur-
ther show that overexpression of hnRNPF in induced Tregs
(iTregs) reduced their ability to suppress the proliferation of
activated CD4 T cells. Taken together, these data suggest a
novel function for FOXP3 to modulate pre-mRNA alternative
splicing through its interaction with splicing factor hnRNPF.
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Results
Association of FOXP3 and hnRNPF protein
We carried out yeast two-hybrid screen with a cDNA library
of in vitro–generated humanCD4CD25Treg cells to under-
stand the mechanism of transcriptional activity by FOXP3 (7).
A cDNA clone encoding the C-terminal 2/3 of hnRNPF protein
was isolated. To confirm the association of FOXP3 hnRNPF in
mammalian cells, we cloned the full-length coding region of
human hnRNPF into a vector plasmid to express a FLAG-tag at
the N-terminal of hnRNPF protein, and used it in co-immuno-
precipitation analysis with full-length FOXP3. FOXP3 was
co-immunoprecipitated with FLAG-tagged hnRNPF but not
FLAG-tag alone, which indicated the association of these two
proteins in mammalian cells (Fig. 1A). This association of
FOXP3 with hnRNPF was not RNA-dependent as RNase A
treatment did not disrupt their interaction (Fig. 1A).
To determine the interacting region of FOXP3 and hnRNPF
proteins, we generated various truncation constructs (Fig. 1B)
and transfected HEK293T cells. Whereas full-length FOXP3
co-immunoprecipitated with FLAG-tagged hnRNPF protein,
FOXP3 lacking the region encoded by exon 2 did not (Fig. 1C).
Deletion of the C-terminal GY-rich domain of hnRNPF did not
disrupt the association with FOXP3 (Fig. 1D). However, an
hnRNPF mutant lacking the first two quasi-RNA recognition
motifs (qRRM) completely abolished the association with
FOXP3, indicating that these two qRRMswere required to bind
to FOXP3. Because the fusion hnRNPF protein associated with
FOXP3 in the original yeast two-hybrid screen contained the
C-terminal half of the second qRRM, the FOXP3-binding site
on hnRNPF is likely located in theC-terminal half of the second
qRRM (qRRM2).We deleted the qRRM2 of hnRNPF and found
that the hnRNPF–RRM2 mutant was localized in the nuclei
(Fig. S2A) but failed to co-immunoprecipitate with FOXP3
(Fig. 1E).
hnRNPF belongs to a family that includes three other pro-
teins, hnRNPH1, hnRNPH2, and hnRNPH3 (21). These pro-
teins show high similarity in the qRRM domains. To examine if
FOXP3 associates with other family members, we cloned cod-
ing regions of hnRNPH1 and hnRNPH3 for co-immunopre-
cipitation analysis. FOXP3 was co-immunoprecipitated with
hnRNPF andH1 but not with hnRNPH3 (Fig. S1A) despite that
both proteins were localized in nuclei (Fig. S2A). Although we
Figure 1. Interaction of FOXP3 and hnRNPF. A, co-immunoprecipitation of human FOXP3 and hnRNPF. HEK293T cells were transfected with plasmid of
FLAG-tagged human hnRNPF and human FOXP3 followed by immunoprecipitation with anti-FLAG antibody. To determine whether FOXP3 and hnRNPF
interaction depends on RNA, some samples were treated with RNase A before immunoprecipitation with anti-FLAG antibody. B, constructs used to map the
interacting regions in FOXP3 andhnRNPF. The results of co-immunoprecipitation shown inC to Ewere also indicated after each construct.C, full-length FOXP3,
but not FOXP3 lacking exon 2 region (FOXP3-E2), co-immunoprecipitated with full-length hnRNPF. D, deletion of the first two quasi-RNA recognition motif
(qRRM) abrogated the interaction between hnRNPF and FOXP3. RRM1  2: hnRNPF with the first two qRRMs deleted; GY, hnRNPF with the C-terminal
GY-rich region deleted. E, deletion of the second quasi-RNA recognition motif (RRM2) abrogated the interaction between hnRNPF and FOXP3.
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failed to express hnRNPH2 in the HEK293T cells, the high
amino acid identity (96%) between hnRNPH1 and hnRNPH2
suggests that FOXP3may also interact with hnRNPH2 protein.
FOXP3modulates alternative splicing by counteracting
hnRNPF activity
hnRNPF is anRNA-binding protein and has been reported to
modulate the alternative splicing of pre-mRNAs, including the
BCL-X gene. hnRNPF promotes the expression of the pro-apo-
ptotic isoform BCL-XS by binding to G-tracts in the 3 half of
exon 2 and facilitating the usage of the alternative 5 splicing
site (22, 23). To understand if the association between FOXP3
and hnRNPF is involved in the regulation of pre-mRNA alter-
native splicing, wemade a humanBCL-Xminigene as described
in “Experimental procedures” and used it in aminigene splicing
assay. HEK293T cells were transfected with a series of plasmids
encoding the BCL-X minigene, FOXP3, and FLAG-hnRNPF
(Fig. 2A). In the absence of FOXP3 and hnRNPF expression
constructs, the minigene generated both large transcript (BCL-
XL) and small transcript (BCL-XS). Consistent with the ability
of hnRNPF to promote BCL-XS expression (22, 23), expression
of exogenous hnRNPF increased the ratio of small to large iso-
forms. By contrast, expression of FOXP3 decreased the ratio of
small to large isoforms in a dose-dependentmanner, both in the
absence and presence of exogenous hnRNPF, which indicates
that FOXP3 represses the splicing activity of hnRNPF (Fig. 2A).
However, increasing hnRNPF dose can overcome the repres-
sion of BCL-XS expression by FOXP3 (Fig. 2B). These data sug-
gest that FOXP3 andhnRNPF reciprocally repress each other in
regulating BCL-X alternative splicing.
Because FOXP3 can associate with other family members
such as hnRNPH1 (Fig. S1A), we carried out theminigene assay
to determine whether this association also affects hnRNPH1
splicing activity. Whereas exogenous hnRNPH1 increases
BCL-XS to BCL-XL ratio, similar to hnRNPF, expression
FOXP3 decreased the ratio (Fig. S1B). These data indicate that
FOXP3 binds to hnRNPF/H family members and represses
their splicing activity.
Exon 2 region but not the forkhead domain of FOXP3 is
required tomodulate hnRNPF activity
Because FOXP3 exon 2 region was required for the interac-
tion with hnRNPF (Fig. 1C), we tested whether the exon 2
region was involved in regulating hnRNPF-mediated alterna-
tive splicing ofBCL-X gene.Whereas transfection of full-length
FOXP3 significantly reduced the ratio of BCL-XS to BCL-XL
expression in the presence or absence of hnRNPF overexpres-
sion, expression of FOXP3 E2 showed no effects on BCL-X
alternative splicing (Fig. 3A).
FOXP3 is a transcription factor with a functional DNA-bind-
ing domain, the forkhead domain (FKH domain). To test
whether forkhead domain is involved in regulating RNA alter-
native splicing, we replaced the forkhead domain of FOXP3
with or without the nuclear localization signal of SV40 large T
antigen (FOXP3-FKHNLS and FOXP3-FKH) (Fig. 3B).
Without the nuclear localization signal, the FOXP3-FKH
mutant failed to enter cell nuclei (Fig. S2B). Minigene splicing
assay was performed with these constructs. Although the cyto-
plasmic FOXP3-FKH did not shift the BCL-X alternative
splicing, the mutant with nuclear localization signal (FOXP3-
FKHNLS) was as active as the intact FOXP3 in repressing
the splicing of BCL-XS isoform in the absence or presence of
exogenous hnRNPF, indicating that the nuclear localization but
not the forkhead domain per se is required for the splice-mod-
ifying activity of FOXP3 protein (Fig. 3B). Taken together, the
association of FOXP3 with hnRNPF reduced the splicing activ-
ity of hnRNPF, and the reduction depends on the exon 2 region
that interacts with hnRNPF but not on the DNA-binding fork-
head domain of FOXP3.
FOXP3 and hnRNPF interaction suppresses hnRNPF binding to
BCL-X pre-mRNA
hnRNPF promotes the expression of BCL-XS isoform by
binding to the G-tracts in exon 2 (22, 23). Mutation in the
G-tracts of the BCL-X gene abolishes the binding of hnRNPF to
BCL-X pre-mRNA and the activity of hnRNPF to modulate
BCL-X alternative splicing. To examine if the splicing of BCL-X
Figure 2. FOXP3 interacts with hnRNPF tomodulate alternative splicing of human BCL-Xminigene. A, expression of human hnRNPF increased the ratio
of small isoform of BCL-Xminigene in HEK293T cells, whereas expression of FOXP3 repressed the small isoform expression. Top panel shows the ratio of small
isoform to large isoform based on RT-PCR results.Middle panel shows the gel image of RT-PCR products. Bottom panel shows the expression of hnRNPF and
FOXP3detected byWestern blotting. B, increased expression of hnRNPF repressed the activity of FOXP3 in a dose-dependentmanner. Data representmean
S.D. (n 3). *, p 0.05; **, p 0.01; ***, p 0.001; ns, not significant; by one-way analysis of variance (ANOVA) with Bonferroni post hoc test.
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minigene is regulated through the same mechanism, we
mutated the two G-tracts that are crucial for hnRNPF binding.
TheWT BCL-Xminigene gave rise to both isoforms and splic-
ing was regulated by both hnRNPF and FOXP3 (Fig. 4A).Muta-
tion of G-tracts in the BCL-X minigene abrogated the splicing
of small isoform. Next, we knocked down the endogenous
expression of hnRNPF and hnRNPH in HEK293T cells with
small interfering RNA (siRNA), and then transfected the cells
with the humanBCL-Xminigene andFOXP3plasmid.Western
blotting showed the knockdown of both hnRNPF (Fig. 4B) and
hnRNPH (data not shown) expression 48 h after siRNA treat-
ment. At this time point, the ability of FOXP3 to modulate
BCL-X splicing was greatly reduced.
We then carried out RNA precipitation to examine whether
association of FOXP3 reduces the binding of hnRNPF to target
RNA. HEK293T cells were transfected with FOXP3 or control
plasmid. RNA precipitation was performed with mAb that rec-
ognizes both hnRNPF and hnRNPH (Fig. 4C). Expression of
FOXP3 significantly reduced the amount of BCL-X pre-mRNA
co-precipitated with hnRNPF/H. Taken together, these data
suggest that FOXP3 suppresses the splicing activity of
hnRNPF/H by interfering with the binding of hnRNPF/H to its
target RNA.
Alternative splicing of hnRNPF/H target gene Tarbp2 in
conventional T cells and Treg cells
To further examine the physiological implications of the
interactions between FOXP3 and hnRNPF, we examined alter-
native splice forms in primary mouse Treg cells. To determine
co-expression of FOXP3 and hnRNPF in Tregs, we stained
mouse splenocytes with fluorochrome-labeled antibodies
against FOXP3 and hnRNPF and examined by fluorescent
microscopy. hnRNPF (stained red) was ubiquitously expressed
in splenocytes and co-expressed with FOXP3 in Tregs that are
stained green (Fig. 5A). The co-expression of hnRNPF and
FOXP3 in Tregs was further supported by FACS analysis on
lymphocytes stained with CD4, FOXP3, and hnRNPF antibod-
ies (Fig. 5B). Although expressed in both conventional CD4 T
cells and Tregs, hnRNPF expression in Tregs (mean fluores-
cence intensity  12,680) was slightly higher than in conven-
tional CD4 T cells (mean fluorescence intensity  11,050).
Using the mAb that recognizes both mouse hnRNPF and
hnRNPH, we demonstrated co-immunoprecipitation of hnRNPF/
Hand FOXP3 inmouse Tregs, suggesting the ability of interac-
tion between these endogenous proteins (Fig. 5C).
Our biochemical analysis in Figs. 1–4 demonstrated that the
interaction between human FOXP3 and hnRNPF regulates the
splicing of BCL-X RNA. Unlike human Tregs that express both
BCL-X isoforms (Fig. S3), mouse Tregs only express the
BCL-XL isoform, which prevented us from analyzing the regu-
lation of mouse BCL-X isoforms by hnRNPF and FOXP3 in
primary mouse Tregs. Because human TARBP2 was identified
as a target of hnRNPH1 by high throughput analysis and RT-
PCR (24), we examined the mouse Tarbp2 sequence and
located putative hnRNPF/H binding sites in intron 8 between
exons 8 and 9 (Fig. 5D). Based upon the location of this putative
binding site, we predict that hnRNPF/H would promote the
splicing out of intron 8, whereas FOXP3 should promote the
inclusion of the intron to express the long Tarbp2mRNA (Fig.
5D diagram). We then cloned exon 7 to exon 9 genomic frag-
ment from mouse Tarbp2 gene and constructed a minigene to
performminigene assay. As predicted, transfection of hnRNPF
significantly increased the ratio of short isoform to long isoform
whereas overexpression of FOXP3 significantly decreased this
ratio regardless of hnRNPF transfection (Fig. 5D).
To determine endogenous Tarbp2 isoform expression in
Tregs and conventional CD4 T cells (Tconv), we sorted Tregs
and Tconv cells from Foxp3eGFP mice and carried out RT-PCR
on the total RNA with primers matching exon 7 and exon 9 of
Figure 3. Modulation of hnRNPF-mediated alternative splicing of human BCL-X minigene by FOXP3 requires exon 2 region but not DNA-binding
forkhead domain. A, repression of hnRNPF-mediated BCL-XS expression required the exon 2 region of FOXP3. B, repression of hnRNPF-mediated BCL-XS
expression did not rely on the DNA-binding domain of FOXP3, the forkhead domain. FOXP3-FKHNLS: forkhead domain deleted FOXP3 with a nuclear
localization signal from SV40 large T antigen; FOXP3-FKH: forkhead domain deleted FOXP3. Data represent mean S.D. (n 3). *, p 0.05; **, p 0.01; ***,
p 0.001; ns, not significant; by one-way ANOVA with Bonferroni post hoc test.
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mouse Tarbp2. Tregs expressed lower ratio of short isoform to
long isoform when compared with conventional T cells (Fig.
5E). To further determine regulation ofTarbp2 isoform expres-
sion by hnRNPF/H, we knocked down hnRNPF and hnRNPH
expression in iTregs with Thy1.1 retrovirus expressing
shRNA targeting hnRNPF and hnRNPH. iTregs with
(GFPThy1.1) or without (GFPThy1.1) retroviral trans-
duction were FACS purified and Tarbp2 isoform expression
was examinedwith RT-PCR. Similar to ex vivo experiment (Fig.
5E), Tarbp2 expression in iTregs is shifted toward the long iso-
form, resulting in lower ratio of short to long isoforms than that
in naïve CD4 T cells (Fig. 5F). Whereas the scrambled control
shRNA did not change the ratio of the Tarbp2 isoforms,
shRNA-mediated knocking down hnRNPF and hnFNPH
expression further increasedTarbp2 long isoformexpression in
iTregs (Fig. 5F). These data suggest that hnRNPF/H proteins
regulate endogenous gene Tarbp2 splicing, and FOXP3may be
able to shift the balance ofTarbp2 isoforms in Tregs. Shifting of
isoform expression will likely cause functional changes of
TARBP2 because inclusion of intron 8 results in a protein
isoform lacking the C-terminal protein–protein interaction
domain.
Overexpression of hnRNPF reduced the suppressive activity of
iTregs
Because FOXP3 is a master transcription factor for Tregs,
alterations in FOXP3 expression will likely result in changes of
transcriptional profile and thus development and function of
Tregs. To explore whether changes in alternative splicing affect
Treg function, we overexpressed hnRNPF in iTregs that would
antagonize FOXP3 in regulating pre-mRNA alternative splic-
ing. We transduced CD4 T cells from Foxp3eGFP mice with
Thy1.1–hnRNPF or control retrovirus during the induction of
iTregs. Transduction of retrovirus expressing hnRNPF does
not significantly affect iTreg differentiation (Fig. 6A), nor does
the expression levels of key Treg phenotypic gene products
FOXP3, CD25, and CTLA4 (Fig. 6B). To study the function of
iTregswith orwithout hnRNPFoverexpression, the transduced
iTregs were sorted by the expression of eGFP and Thy1.1. The
purified iTregs were co-cultured with CFSE-labeled naïve CD4
T cells isolated from congenic CD45.1 mice under TCR stimu-
lation. The proliferation of CD45.1 responder CD4 T cells
was examined 4 days later. Overexpression of hnRNPF in
iTregs significantly reduced their suppression of responder
CD4 T cell proliferation when they were co-cultured at 1:1 to
1:4 ratios (Fig. 6C). The difference in suppression between
hnRNPF transduced and control transduced iTregs was atten-
uated by the decreasing ratio of iTregs to responders. These
data indicate that overexpression of hnRNPF reduces the ability
of FOXP3 to confer suppressive activity even though the
expression level of FOXP3 is not impacted.
Discussion
Expression of FOXP3 is essential for Treg cell differentiation
irrespective ofwhether theT cells commit to theTreg lineage in
the thymus or in the periphery. Because of its ability to bind to
DNA through the FKH domain and to interact with numerous
transcription factors and chromatin modifiers (25), the major-
ity of studies on the mechanisms by which FOXP3 governing
Treg lineage commitment and maintenance focus on FOXP3-
mediated transcriptional regulation. For the first time, our
study provides evidence that FOXP3 interacts with and limits
hnRNPF and hnRNPH binding to pre-mRNA and modulating
alternative splicing of target genes. In the context of already
complex transcriptional and epigenetic actions of FOXP3, our
finding adds another layer of posttranscriptional regulation of
gene expression by FOXP3 in Treg development and function.
FOXP3 forms macromolecular complexes with 361 associ-
ated proteins in an unbiased proteomics analysis and 23% of
identified FOXP3 protein partners have been implicated in RNA
binding and regulation (16). Although hnRNPF was not included
in the previous report, themain function of the reported hnRNPL
and hnRNPLLproteins, similar to hnRNPF/H familymembers, is
regulation of RNA alternative splicing. The discrepancy in
identifying hnRNPF as FOXP3-associated protein in our study
and hnRNPL/hnRNPLL as FOXP3partners could be because of
the difference in originalmaterial and approach used.While we
used a yeast two-hybrid screen with a library constructed
with cDNA from human Tregs (7), Rudra et al. (16) used mass
spectrometric analyses of retrovirus (encoding biotinylated
Figure 4. Interaction of FOXP3 with hnRNPF suppresses the binding of hnRNPF to its target BCL-X pre-mRNA. A, mutations of the G-tracts on BCL-X
minigenewherehnRNPFbindingabrogated the splicingof short isoformBCL-XS.B, knockingdownhnRNPFandhnRNPHexpressioneliminatedFOXP3’s ability
tomodulateBCL-X alternative splicing. Toppanel,Westernblottingdetectionof hnRNPFexpression inHEK293T cells transfectedwith siRNAs targetinghnRNPF
and hnRNPH. Bottom panel, 24 h after siRNA transfection, cells were transfected with plasmids for BCL-Xmingene and FOXP3. Cells were harvested for RT-PCR
48 h after siRNA transfectionwhenhnRNPF expressionwas the lowest.C, FOXP3 suppressed endogenous hnRNPF/Hbinding to endogenous BCL-Xpre-mRNA.
RIP assay was carried out as described under “Experimental procedures.” Data representmean S.D. (n 3). **, p 0.01; ***, p 0.001; ns, not significant; by
one-way ANOVA with Bonferroni post hoc test.
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FOXP3)-transduced T cell hybridoma TCli. Nevertheless, the
inclusion of multiple splicing factors in the FOXP3 macromo-
lecular complexes in mice supports the idea that FOXP3 is
capable of regulating RNA alternative splicing to modulate
Treg development and/or function.
Alternative splicing of multi-exon genes often yields protein
products with different, even opposite, physiological and cellu-
lar functions. For example, the two alternatively spliced iso-
forms BCL-XS and BCL-XL from the single gene BCL-X have
been associated, respectively, with the promotion and the pre-
vention of apoptosis. The balanced ratio of two isoforms is
important for cell survival. hnRNPF promotes the production
of the pro-apoptotic BCL-XS variant (22, 23, 26). Our results
show that FOXP3 interacting with hnRNPF is capable of low-
ering the BCL-XS/BCL-XL ratio (Fig. 3). In mice, BCL-XL was
shown to be required for the development of functional Tregs
in lupus-afflicted mice following treatment with a tolerogenic
peptide (27), and FOXP3 and BCL-XL cooperatively promoted
Figure 5. Regulation of alternative splicing of hnRNPF/H target gene Tarbp2 in mouse Tregs. A, co-expression of mouse FOXP3 and hnRNPF. Mouse
splenocytes were stained with Texas Red anti-mouse hnRNPF and FITC anti-mouse FOXP3, and analyzed under fluorescent microscope. B, FACS analysis of
mouse FOXP3 and hnRNPF co-expression was carried out on mouse lymphocytes stained with fluorochrome-labeled antibodies against CD4, FOXP3, and
hnRNPF. Cells were gated on CD4 and the expression of FOXP3 and hnRNPF was determined. C, co-immunoprecipitation of endogenous FOXP3 and
hnRNPF/H in in vitro differentiated mouse regulatory T cells. Immunoprecipitation was performed with a mouse mAb (clone 1G11) that recognizes hnRNPF
and hnRNPH proteins. Normal mouse IgG was added as control ().D, minigene assay demonstrating regulation of Tarbp2 alternative splicing by FOXP3 and
hnRNPF/H. Also shown are a diagram of Tarbp2 gene structure (exon 7 to exon 9), putative binding site (arrowhead) of hnRNPF/H, and predicted regulation of
splicing isoforms by FOXP3 and hnRNPF/H. E, expression of Tarbp2 splicing isoforms in FACS sorted conventional (Tconv) and regulatory (Treg) CD4 T cells. F,
knocking down hnRNPF/H expression in induced Treg (iTreg) cells further shifted Tarbp2 expression to the long isoform. iTregs, while differentiating, were
transducedwith Thy1.1 retrovirus expressing hnRNPF/H targeting shRNA or scrambled control (ctrl) shRNA. iTregs (eGFP) transduced (Thy1.1) or nontrans-
duced (Thy1.1) by the retrovirus were sort purified and Tarbp2 isoform expression was examined by RT-PCR. Data represent mean S.D. (n 3). *, p 0.05;
**, p 0.01; ***, p, 0.001; ns, not significant; by one-way ANOVA with Bonferroni post hoc test (D and F) or two-tailed t test (E).
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Treg persistence and prevention of arthritis development (28).
Whereas mouse Tregs only express the BCL-XL isoform (Fig.
S2) and conditional knockout of Bcl-x gene, which would elimi-
nate both BCL-XL and BCL-XS, in FOXP3 cells did not affect
Treg survival (29), whether changes in the BCL-XS to BCL-XL
ratio because of the interaction between FOXP3 and hnRNPF/H
would impact human Treg development, function, or survival
needs further investigation.
The FKH domain of FOXP3 is important to form
homodimers and for DNA binding (30). The FKH domain also
directly interacts with nuclear factor of activated T cells, and
this interaction was important for transcriptional repression
(for example IL-2) and activation (for example CTLA4) by
FOXP3 (9, 31). Although critical for Treg differentiation and
function, the FKH domain appeared to be dispensable for the
transcriptional control ofmost FOXP3-regulated Treg relevant
genes, and deletion of FKH domain only dysregulates the
expression of 16% of FOXP3 regulated genes (32). Our study
demonstrated that deletion of FKH domain did not abolish the
ability to regulate RNA alternative splicing by FOXP3 (Fig. 3B),
suggesting DNA recognition and binding are not required for
FOXP3 to regulate alternative splicing. In consistency, FOXP3
regulates RNAalternative splicing by limiting hnRNPF/Hbind-
ing to its target RNA (Fig. 4C).
The N-terminal proline-rich region of FOXP3 protein (exon
1 to exon 3) plays a pivotal role in FOXP3-mediated gene
expression control, and 2143 of 2407 FOXP3 target genes are
likely regulated through its proline-rich region (32).Within this
region, FOXP3 exon 2 interacts and inhibits RORt and ROR
function to suppress Th17 differentiation (33, 34). Our results
suggest a novel function of FOXP3 exon 2 that interacts with
splicing factor hnRNPF, and likely hnRNPH1, to regulate
mRNA alternative splicing (Fig. 3A).
Experimental procedures
Mice
WT BALB/c mice and Foxp3eGFP knockin mice were pur-
chased from the Jackson Laboratory (Bar Harbor, Maine). All
animals were housed in specific pathogen-free conditions, and
all studies were approved by the Indiana University School of
Medicine Animal Care and Use Committee.
Cell lines and transfections
HEK293T cells were maintained in complete DMEM con-
taining 5% FBS and 1% penicillin and streptomycin and were
transfected using TransIT-LT1 or TransIT-293. Jurkat cells
were maintained and transfected according to the manuals of
Cell Line Nucleofector Kit V (Amaxa).
Antibodies and reagents
The primary antibodies used include rat anti-FLAG (BioLeg-
end), Alexa Fluor 488 anti-FOXP3 (eBioscience), anti-FOXP3
(clone 150D, BioLegend), anti-FOXP3 (poly6238, BioLegend),
anti-hnRNPF (Sigma), and anti-hnRNPF/H (clone 1G11, Santa
Cruz Biotechnology). Protein AG plus agarose beads were pur-
chased from Santa Cruz Biotechnology.
Plasmids
Human hnRNPF expression plasmid was made by cloning
the coding region without start codon into pCMV-Tag2b
between EcoRI and XhoI sites. hnRNPF-RRM1 2 contains
Figure 6. Retrovirus-mediated hnRNPF overexpression reduces suppressive activity of mouse iTregs. Naïve CD4 T cells from CD45.2 Foxp3eGFP mice
were transduced during induction of iTregs with Th1.1 retroviruses expressing hnRNPF or vector only. A, retrovirus-mediated overexpression of hnRNPF did
not affect iTreg differentiation (eGFP) in Thy1.1 gated CD4 T cells. B, retrovirus-mediated overexpression of hnRNPF did not significantly affect the
expression of key Treg genes FOXP3, CD25, and CTLA4. C, differences in suppression of CD45.1 responder cell proliferation by iTregs with or without hnRNPF
overexpression. Suppressive assay was carried out with sorted iTreg (Thy1.1FOXP3-eGFP) mixed with naïve CD45.1 CD4 T cells as responders in the
presence of plate-bound anti-CD3 and soluble anti-CD28. The ratios of iTregs to responders are indicated. Data represent mean S.D. (n 3). **, p 0.01 by
two-way ANOVA with Bonferroni post hoc test.
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coding region of amino acid 201–415. hnRNPF-GY contains
amino acid 1–366. Human FOXP3 plasmid was made by clon-
ing the coding region plus 6 nucleotides upstream start coding
in pIRES2-eGFP between EcoRI and XbaI. Mouse hnRNPF ret-
roviral plasmid was cloned by inserting the coding region of
mouse hnRNPF with 12 nucleotides upstream start codon into
vector MSCV-IRES-Thy1.1.
HumanBCL-Xminigenewasmade by cloning two fragments
covering part of exon 2, intron 2, and exon 3 into vector
pIRES2-eGFP at BamHI site. The first fragment of human
BCL-X minigene starts with GTACCGGCGGGCATTCAG-
TGAC and ends with CTGTAGGCAAGTTTTGCTCTT; the
second fragment starts withGTAACATGGTTTGATTAT and
ends with CTCACTCTTCAGTCGGAAATGA. To make the
mouse Tarbp2 minigene, a 925-bp genomic fragment from
exon 7 to exon 9 was amplified with primer pair of GTTGTT-
GTCGACGCCACCATGGGCACTTCCAAAAAGCTGGCA-
AAGC and GTTGTTGGATCCGCAGTGGGATGCTACTT-
GCTAC. This genomic fragment was cloned into vector
pIRES2-eGFP between SalI and BamHI sites.
Minigene assay
BCL-X minigene assay for alternative splicing was adapted
from published methods (22, 23). HEK293T cells were trans-
fected with BCL-X minigene and constructs expressing hnRNPF
and FOXP3 mutants. 24 h after transfection, RNA was
extracted with TRIzol reagent (Invitrogen) and reverse tran-
scribed into cDNA with High Capacity cDNA Reverse Tran-
scription Kit (Applied Biosystems). PCR was performed on the
cDNAwith aminigene-specific forward primer (CATTCAGT-
GACCTGACATCCCA) and a reverse primer that located
on pIRES2 vector (ACAGACCTTGCATTCCTTTGGC) and
resolved on 2% agarose gel. Ethidium bromide–stained gels
were captured by Gel Logic 2200 Imaging System (Carestream)
and the band intensities of BCL-XS and BCL-XL were quanti-
fied by Image J software. Mouse Tarbp2 minigene assay was
performed similarly as described above except that PCR was
performedwith the forward primer that was used for cloning of
theTarbp2minigene. Allminigene assays were performedwith
triplicates and repeated at least twice.
Co-immunoprecipitation
24 h after transfection, Jurkat cells and HEK293T cells were
washed with ice-cold PBS and then resuspended in 450 l of
ice-cold lysis buffer (50mMTris-HCl, pH 8.0, 120mMNaCl, 1%
Nonidet P-40, 4 mM EDTA, 50 mM NaF, 1 mM Na3VO4, 2
g/ml aprotinin, 1 g/ml leupeptin, 1 g/ml pepstatin A). The
cells were sonicated and centrifuged. The supernatant was
transferred to a fresh tube containing 400 l of lysis buffer and
precleared with protein AG plus agarose beads (Santa Cruz
Biotechnology) for 1 h before 4 g of anti-FLAG was added.
Immunoprecipitates were collected with protein AG plus.
Western blotting was conducted using rabbit anti-FOXP3,
mouse monoclonal anti-FOXP3 (clone 150D), or anti-FLAG
antibodies.
To verify interaction of endogenous hnRNPF/H and FOXP3
in mouse regulatory T cells, naïve CD4 T cells were differenti-
ated in vitro into iTregs (see “iTreg induction and suppressive
function assay” for details). iTregs were processed as described
above, precipitated with mouse anti-hnRNPF/H mAb (clone
1G11, Santa Cruz Biotechnology) or normal mouse IgG. Co-
immunoprecipitation of hnRNPF/H and FOXP3 were exam-
ined by Western blotting using anti-hnRNPF/H and anti-
FOXP3 antibodies.
Retrovirus transduction
Retrovirus was generated by transfecting Plat E cells with
TransIT-293 and specific retroviral plasmid. Retrovirus was
harvested between 48 and 72 h after transfection and was sup-
plemented with 9 g/ml of polybrene just before T cell trans-
duction. T cells were transduced on day 2 of TCR stimulation at
2000 rpm for 2 h at room temperature.
iTreg induction and suppressive function assay
Mouse naïve CD4 T cells were isolated with magnetic bead
sorting as described (35). For iTreg induction, naïveCD4T cells
isolated from Foxp3eGFP mice were stimulated for 4 to 5 days
with 1 g/ml plate-bond anti-CD3 (145–2C11) and 1 g/ml
soluble anti-CD28 in the presence of 5 ng/ml recombinant
human TGF- 1 and 20 ng/ml recombinant mouse IL-2.
To examine the effect of hnRNPF overexpression on iTreg
suppressive function, iTregs were transduced with retrovirus
encoding hnRNPF and Thy1.1 marker on day 2 of differentia-
tion. On day 5, transduced iTregs were sorted by the expression
of eGFP and retroviral marker Thy1.1. Suppressive function
assay was carried out in round bottom 96-well plate that was
coated with 2 g/ml anti-CD3. 2.5 	 104 CFSE-labeled naïve
CD4T cells of CD45.1mice were cultured with sorted iTregs at
a series of ratios in the presence of 1.2g/ml soluble anti-CD3
and 3.5 g/ml anti-CD28. 4 days after culture, CFSE intensity
was examined for the CD45.1 cells by flow cytometry.
RNA immunoprecipitation
HEK293T cells were transfected with expression plasmid of
FOXP3 or vector only. 2 days after transfection, cells were fixed
with 1% formaldehyde for 10min afterwashingwithDulbecco’s
PBS (Invitrogen). Fixation was stopped by 0.25 M glycine for 5
min. Cells were then harvested and suspended with nuclear
isolation buffer (1.28M sucrose, 40mMTris-HCl, pH 7.5, 20mM
MgCl2, 4% Triton X-100) supplemented with proteinase inhib-
itor mixture (Roche). Cells were incubated on ice for 20 min
with frequent mixing. Nuclei were precipitated by centrifuga-
tion at 2500	 g for 15min.Nuclei were then suspended inRNA
immunoprecipitation (RIP) buffer (150 mM KCl, 25 mM Tris,
pH 7.4, 5 mM EDTA, 0.5 mM DTT, 0.5% Nonidet P-40, 100
units/ml RNase inhibitor and protease inhibitors), sonicated,
and centrifuged at 15,000	 g for 10 min. The supernatant was
precleared with salmon sperm DNA blocked Protein A/G plus
bead (Santa Cruz Biotechnology) for 30 min at 4 °C. Immuno-
precipitation was then performed by adding hnRNPF/H mAb
(clone 1G11, Santa Cruz Biotechnology) to the precleared
supernatant followed by incubation at 4 °C with rotating over-
night. Protein A/G plus bead blocked with salmon sperm DNA
was then added and incubated with rotating at 4 °C for 3 h. The
beads were then washed with RIP buffer for three times fol-
lowed by proteinase K digestion. Cross-link was reversed with
FOXP3modulates RNA alternative splicing
10242 J. Biol. Chem. (2018) 293(26) 10235–10244
0.3 M NaCl at 65 °C for 5 h. Glycogen was added before RNA
isolation with TRIzol reagent. BCL-X pre-mRNA co-immuno-
precipitated with hnRNPF/H was quantified by RT-qPCR.
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